Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Santus, LLC (also known as Santus Laboratories) is a consumer healthcare and medical products company that specializes in branded and private-label dermatology and skincare products. Founded in 2015 through a joint venture between HealthEdge Investment Partners and Ambassador Enterprises, the company acquired the legacy skincare brands Lantiseptic and Boroleum from Summit Industries. Lantiseptic is a line of lanolin-based over-the-counter (OTC) products used to prevent and treat skin irritations, particularly in institutional settings like hospitals and nursing homes. Boroleum is a time-tested analgesic ointment used for the relief of nasal and facial discomfort. In August 2018, Santus was acquired by DermaRite Industries, a manufacturer of skin and wound care products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Santus.